[{"NetIncomeLoss_1_Q3_USD":-3801000.0,"AccruedLiabilitiesCurrent_0_Q3_USD":6845000.0,"InventoryFinishedGoodsNetOfReserves_0_Q3_USD":1808000.0,"InterestPaidNet_3_Q3_USD":3910000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q3_USD":840000.0,"RestrictedCashAndCashEquivalentsNoncurrent_0_Q3_USD":150000.0,"EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_0_Q3_USD":4100000.0,"PaymentsForRestructuring_2_Q3_USD":320000.0,"NetCashProvidedByUsedInInvestingActivities_3_Q3_USD":-170000.0,"Depreciation_3_Q3_USD":135000.0,"StockIssuedDuringPeriodValueNewIssues_3_Q3_USD":24701000.0,"StockIssuedDuringPeriodValueNewIssues_1_Q3_USD":4711000.0,"IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets_3_Q3_USD":-2494000.0,"FinanceLeaseInterestPaymentOnLiability_3_Q3_USD":7000.0,"FinanceLeaseInterestPaymentOnLiability_1_Q3_USD":2000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q3_USD":815000.0,"AssetsCurrent_0_Q3_USD":47592000.0,"OperatingLeaseExpense_3_Q3_USD":640000.0,"InventoryWorkInProcessNetOfReserves_0_Q3_USD":1058000.0,"CommonStockSharesIssued_0_Q3_shares":131421846.0,"FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q3_USD":14000.0,"FinanceLeaseLiabilityUndiscountedExcessAmount_0_Q3_USD":5000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q3_USD":849000.0,"StockIssuedDuringPeriodValueShareBasedCompensation_3_Q3_USD":-90000.0,"PaidInKindInterest_3_Q3_USD":977000.0,"FinanceLeaseInterestExpense_1_Q3_USD":2000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q3_shares":15346761.0,"SellingAndMarketingExpense_1_Q3_USD":5269000.0,"SellingAndMarketingExpense_3_Q3_USD":19483000.0,"FinanceLeaseLiabilityNoncurrent_0_Q3_USD":12000.0,"RestructuringCharges_2_Q3_USD":590000.0,"OperatingLeaseExpense_1_Q3_USD":213000.0,"FinanceLeaseInterestExpense_3_Q3_USD":7000.0,"CommitmentsAndContingencies_0_Q3_USD":null,"AccountsAndOtherReceivablesNetCurrent_0_Q3_USD":9392000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q3_shares":127945000.0,"CommonStockValue_0_Q3_USD":131000.0,"OtherNonoperatingIncomeExpense_1_Q3_USD":-4000.0,"OtherNonoperatingIncomeExpense_3_Q3_USD":58000.0,"GainsLossesOnExtinguishmentOfDebt_1_Q3_USD":0.0,"GainsLossesOnExtinguishmentOfDebt_3_Q3_USD":0.0,"FinanceLeasePrincipalPayments_1_Q3_USD":15000.0,"NetCashProvidedByUsedInFinancingActivities_3_Q3_USD":27012000.0,"FinanceLeasePrincipalPayments_3_Q3_USD":35000.0,"FiniteLivedIntangibleAssetsAccumulatedAmortization_0_Q3_USD":42498000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q3_USD":3950000.0,"ResearchAndDevelopmentExpense_1_Q3_USD":4090000.0,"ResearchAndDevelopmentExpense_3_Q3_USD":12219000.0,"ClassOfWarrantOrRightOutstanding_0_Q3_shares":486812.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q3_USD":221000.0,"ContractWithCustomerAssetAccumulatedAllowanceForCreditLoss_0_Q3_USD":1715000.0,"Assets_0_Q3_USD":76791000.0,"FinanceLeaseLiabilityPaymentsDue_0_Q3_USD":69000.0,"FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q3_USD":55000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_3_Q3_shares":122768000.0,"GeneralAndAdministrativeExpense_1_Q3_USD":5796000.0,"GeneralAndAdministrativeExpense_3_Q3_USD":14949000.0,"PreferredStockSharesOutstanding_0_Q3_shares":0.0,"OperatingLeaseLiability_0_Q3_USD":3028000.0,"FinanceLeaseLiability_0_Q3_USD":64000.0,"IncreaseDecreaseInInventories_3_Q3_USD":1503000.0,"Liabilities_0_Q3_USD":69197000.0,"OperatingLeaseLiabilityNoncurrent_0_Q3_USD":2483000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q3_USD":28726000.0,"AmortizationOfIntangibleAssets_1_Q3_USD":615000.0,"AmortizationOfIntangibleAssets_3_Q3_USD":1845000.0,"ComprehensiveIncomeNetOfTax_1_Q3_USD":-3801000.0,"ComprehensiveIncomeNetOfTax_3_Q3_USD":-29925000.0,"AdditionalPaidInCapitalCommonStock_0_Q3_USD":501834000.0,"ShareBasedCompensation_3_Q3_USD":4284000.0,"OperatingLeaseRightOfUseAsset_0_Q3_USD":2733000.0,"PreferredStockParOrStatedValuePerShare_0_Q3_USD":0.001,"NonoperatingIncomeExpense_1_Q3_USD":-1844000.0,"NonoperatingIncomeExpense_3_Q3_USD":-5372000.0,"AccountsPayableCurrent_0_Q3_USD":5185000.0,"DeferredRevenueCurrent_0_Q3_USD":300000.0,"LiabilitiesCurrent_0_Q3_USD":12927000.0,"LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q3_USD":889000.0,"InterestExpense_3_Q3_USD":5430000.0,"InventoryRawMaterialsNetOfReserves_0_Q3_USD":776000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_1_Q3_USD":0.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_3_Q3_USD":0.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q3_USD":2389000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_3_Q3_USD":4284000.0,"PaymentsRelatedToTaxWithholdingForShareBasedCompensation_3_Q3_USD":90000.0,"FinanceLeaseWeightedAverageDiscountRatePercent_0_Q3_pure":0.125,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-20330000.0,"CommonStockSharesOutstanding_0_Q3_shares":131421846.0,"InterestExpense_1_Q3_USD":1840000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q3_USD":5832000.0,"NetIncomeLoss_3_Q3_USD":-29925000.0,"PropertyPlantAndEquipmentNet_0_Q3_USD":492000.0,"PreferredStockSharesIssued_0_Q3_shares":0.0,"OperatingLeasePayments_1_Q3_USD":216000.0,"OperatingLeasePayments_3_Q3_USD":646000.0,"FiniteLivedIntangibleAssetsNet_0_Q3_USD":25824000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q3_USD":28876000.0,"StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_1_Q3_USD":107000.0,"ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_0_Q3_USD":1.23,"OperatingLeaseWeightedAverageDiscountRatePercent_0_Q3_pure":0.125,"FinanceLeaseRightOfUseAssetAmortization_1_Q3_USD":13000.0,"FinanceLeaseRightOfUseAssetAmortization_3_Q3_USD":39000.0,"OtherAccruedLiabilitiesCurrent_0_Q3_USD":1227000.0,"LongTermDebtNoncurrent_0_Q3_USD":50775000.0,"StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_3_Q3_USD":294000.0,"IncreaseDecreaseInContractWithCustomerLiability_3_Q3_USD":285000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_3_Q3_USD":6512000.0,"VariableLeaseCost_1_Q3_USD":9000.0,"LiabilitiesAndStockholdersEquity_0_Q3_USD":76791000.0,"PreferredStockValue_0_Q3_USD":0.0,"FiniteLivedIntangibleAssetsGross_0_Q3_USD":68322000.0,"RestructuringReserve_0_Q3_USD":270000.0,"InventoryNet_0_Q3_USD":3642000.0,"OperatingIncomeLoss_1_Q3_USD":-1957000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q3_USD":3463000.0,"OperatingIncomeLoss_3_Q3_USD":-24553000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_3_Q3_USD":27306000.0,"CommonStockSharesAuthorized_0_Q3_shares":300000000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q3_USD":1176000.0,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q3_USD":922000.0,"CommonStockParOrStatedValuePerShare_0_Q3_USD":0.001,"ProceedsFromIssuanceOfCommonStock_3_Q3_USD":24802000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q3_USD":15695000.0,"RetainedEarningsAccumulatedDeficit_0_Q3_USD":-495211000.0,"PreferredStockSharesAuthorized_0_Q3_shares":5000000.0,"AllocatedShareBasedCompensationExpense_1_Q3_USD":2389000.0,"VariableLeaseCost_3_Q3_USD":27000.0,"PaymentsToAcquirePropertyPlantAndEquipment_3_Q3_USD":170000.0,"StockholdersEquity_0_Q3_USD":7594000.0,"OtherLiabilitiesCurrent_0_Q3_USD":597000.0,"FinanceLeaseLiabilityCurrent_0_Q3_USD":52000.0,"OtherLiabilitiesNoncurrent_0_Q3_USD":3012000.0,"AllocatedShareBasedCompensationExpense_3_Q3_USD":4284000.0,"ProfitLoss_3_Q3_USD":-29925000.0,"EarningsPerShareBasicAndDiluted_3_Q3_USD":-0.24,"IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_3_Q3_USD":589000.0,"OperatingExpenses_1_Q3_USD":17652000.0,"OperatingExpenses_3_Q3_USD":51859000.0,"OperatingLeaseLiabilityCurrent_0_Q3_USD":545000.0,"FinanceLeaseRightOfUseAsset_0_Q3_USD":61000.0,"EarningsPerShareBasicAndDiluted_1_Q3_USD":-0.03,"AccruedProfessionalFeesCurrent_0_Q3_USD":739000.0,"Ticker":"EYPT","CIK":"1314102","name":"EYEPOINT PHARMACEUTICALS, INC.","OfficialName":"EyePoint Pharmaceuticals Inc. Common Stock","form":"10-Q","period":"20200930","fy":"2020.0","fp":"Q3","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"408871503.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20201106"}]